- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Status
Ongoing
Phase
Open Label
Principal Investigator(s)
Moses Kamya, MBChB, PhD, Maya Petersen, PhD
Objective
The SEARCH study aims to test evidenced-based innovative community based interventions that lead to the elimination of HIV in rural communities in East Africa using a multi-disease approach. The first phase of the study will quantify the health, economic and educational impact of early HIV diagnosis using a streamlined and immediate ART (antiretroviral therapy). This first phase will be completed in July 2017. The second phase of the study, will quantify the health, economic and educational impact of targeted Pre-Exposure Prophylaxis (PrEP), targeted HIV testing and targeted care interventions in the context of universal treatment and streamlined care. This second phase will be completed in July 2020. The study intervention is designed to improve the entire continuum of care, to reduce structural barriers for all populations including those most "at risk".
Prevention Option(s)
PrEP
Treatment
Study Design
Randomized
Open label
Arms and Assigned Interventions
Description
Intervention arm first phase: annual universal community-based HIV and multi-disease testing; ART for all HIV+ using streamlined care delivery
Intervention arm second phase: baseline universal community-based HIV and multi-disease testing; ART for all HIV+ using streamlined care delivery + targeted PrEP, targeted HIV testing, and targeted care interventions
Products
TDF/FTC (Truvada)
ARMs
Experimental
Description
Intervention arm first phase: baseline community-based HIV and multi-disease testing
Intervention arm second: baseline universal community-based HIV and multi-disease testing; ART for all HIV+ using streamlined care delivery
ARMs
Placebo Comparator
Official Code
Trial Sponsors
University of California, San Francisco, IDRC, Makerere University, Kenya Medical Research Institute, Gilead Sciences, World Bank, NIAID, PEPFAR
April 2013
December 2018
Enrollment
340 000
Population
Women
Men
Sites
Nyanza Province
Kenya
Eastern Uganda
Mbale/Tororo region
Uganda
Southwestern Uganda
Mbarara region
Uganda